Compare

Edesa Biotech, Inc. vs CalciMedica, Inc. vs Chemomab Therapeutics Ltd. vs CytoDyn Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Edesa Biotech, Inc. EDSA	CalciMedica, Inc. CALC	Chemomab Therapeutics Ltd. CMMB	CytoDyn Inc. CYDY
Year ended	2025-09-30	2025-12-31	2025-12-31	2026-05-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$7.19M	-$29.56M	-$8.99M	-$42.70M
EPS (Diluted)	n/a	-$1.97	$0.018	-$0.03
Operating cash flow	-$7.32M	-$21.18M	-$11.13M	-$17.25M
Free cash flow	n/a	-$21.21M	-$11.13M	n/a
Cash & equivalents	$10.80M	$11.52M	$7.56M	$11.85M
Total assets	$13.53M	$13.59M	$13.81M	$13.97M
Total liabilities	n/a	$20.23M	$1.48M	$123.69M
Shareholders' equity	$12.45M	-$6.64M	$12.33M	-$109.72M
Return on year-end equity	-57.7%	n/a	-72.9%	n/a
Shares outstanding	7.14M	15.44M	n/a	1.37B

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Edesa Biotech, Inc.	CalciMedica, Inc.	Chemomab Therapeutics Ltd.	CytoDyn Inc.
Latest	$0 Ended 2021-09-30	n/a	n/a	$0 Ended 2023-05-31
1 year earlier	$328.8K Ended 2020-09-30	n/a	n/a	$266.0K Ended 2022-05-31
2 years earlier	n/a	n/a	n/a	$0 Ended 2021-05-31
3 years earlier	$211.8K Ended 2018-09-30	n/a	n/a	n/a
4 years earlier	$228.3K Ended 2017-09-30	n/a	n/a	n/a